Home | All trials

[RDF data]
Trial NCT00000273

Resource URI: http://static.linkedct.org/resource/trials/NCT00000273
PropertyValue
linkedct:arm_group <http://static.linkedct.org/resource/arm_group/55255>
linkedct:brief_title A Laboratory Model for Heroin Abuse Medications - 8
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/5652>
linkedct:condition <http://static.linkedct.org/resource/condition/12664>
linkedct:condition <http://static.linkedct.org/resource/condition/5932>
linkedct:condition <http://static.linkedct.org/resource/condition/9249>
linkedct:criteria Please contact site for information.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 45 Years
linkedct:eligibility_minimum_age 18 Years
linkedct:end_date December 2009
linkedct:enrollment 37 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:has_dmc Yes
linkedct:id NCT00000273
linkedct:intervention <http://static.linkedct.org/resource/intervention/99999>
rdfs:label Trial NCT00000273
linkedct:lastchanged_date July 8, 2009
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/153896>
linkedct:nct_id NCT00000273
linkedct:number_of_arms 1 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title A Laboratory Model for Heroin Abuse Medications
linkedct:org_study_id NIDA-09236-8
linkedct:overall_contact_email sdc10@columbia.edu
linkedct:overall_contact_last_name Sandra D Comer, Ph.D.
linkedct:overall_contact_phone 212-543-5981
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/22590>
linkedct:overall_status Recruiting
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
linkedct:oversight <http://static.linkedct.org/resource/oversight/2920>
linkedct:oversight <http://static.linkedct.org/resource/oversight/2938>
foaf:page <http://clinicaltrials.gov/show/NCT00000273>
linkedct:phase Phase 2
linkedct:primary_completion_date December 2009
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/51758>
linkedct:secondary_id P50 DA009236-08
linkedct:secondary_outcomes <http://static.linkedct.org/resource/secondary_outcomes/107896>
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date August 1995
linkedct:study_design Treatment, Randomized, Double Blind (Subject, Caregiver, Outcomes Assessor), Placebo Control, Crossover Assignment, Pharmacodynamics Study
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration."
rdf:type linkedct:trials
linkedct:verification_date July 2009